share_log

Co-Diagnostics, Inc. Appoints Richard Abbott As President, Concurrent With The Co Naming David Nielsen To Be Its Chief Operations Officer

Co-Diagnostics, Inc. Appoints Richard Abbott As President, Concurrent With The Co Naming David Nielsen To Be Its Chief Operations Officer

Co-Diagnostics, Inc. 任命理查德·阿伯特爲總裁，同時該公司任命戴維·尼爾森爲其首席運營官
Benzinga ·  04/04 09:31
Co-Diagnostics, Inc. (NASDAQ:CODX) ("Co-Dx" or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that last month the Board of Directors appointed Richard Abbott as President of Co-Diagnostics, Inc., concurrent with the Company naming David Nielsen to be its Chief Operations Officer (COO), Christopher Thurston as its Chief Technology Officer (CTO), and Seth Egan as Chief Commercialization Officer (CCO).
擁有專利分子診斷測試開發平台的分子診斷公司Co-Diagnostics, Inc.（納斯達克股票代碼：CODX）（“Co-Dx” 或 “公司”）今天宣佈，上個月董事會任命理查德·阿伯特爲Co-Diagnostics, Inc.總裁，同時任命戴維·尼爾森爲首席運營官（COO），克里斯托弗·瑟斯頓爲首席技術官（首席技術官），塞思·伊根擔任首席商業化官（CCO）。
Prior to his new role at the Company, Richard Abbott (President) served as the President of Advanced Conceptions, Inc., a wholly-owned subsidiary of Co-Diagnostics...
在公司擔任新職務之前，理查德·阿伯特（總裁）自202...
登入免費觀看全文
登入/註冊
声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論